Asset Details
Do you wish to reserve the book?
Sedative potential of palmatine chloride in thiopental sodium-induced chicks: evidence from in vivo and in Silico studies
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Sedative potential of palmatine chloride in thiopental sodium-induced chicks: evidence from in vivo and in Silico studies
Do you wish to request the book?
Sedative potential of palmatine chloride in thiopental sodium-induced chicks: evidence from in vivo and in Silico studies
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Sedative potential of palmatine chloride in thiopental sodium-induced chicks: evidence from in vivo and in Silico studies
2025
Overview
The aim of this study is to assess the sedative impact of palmatine chloride (PME) in thiopental sodium-induced sleeping chicks and its underlying molecular mechanism by using in vivo and in silico approaches. Chicks received PME per orally (p.o.) at doses of 1.25, 2.5, and 5 mg/kg per body weight (b.w.), while diazepam (DZP) (2 mg/kg) served as a positive control and vehicle as a negative control. For the purpose of evaluating the experimental compounds synergistic or antagonistic effects, a combination of PME and DZP was administered to the chicks. After thirty minutes, thiopental sodium (40 mg/kg, intraperitoneal (i.p.)) was administered to induce sleep, and latency to sleep onset and sleep duration were measured. In vivo results showed that PME reduced sleep latency and prolonged sleep duration in a dose-dependent manner, with the combination therapy producing a significant enhancement of these effects. In silico docking revealed PME binding to gamma-aminobutyric acid A (GABA
A
) receptor α1 and β2 subunits (–7.2 kcal/mol) with shared amino acids. Pharmacokinetic and toxicity analyses suggested favorable drug-like properties. These results indicate PME’s sedative potential, alone or with DZP, likely via GABAergic modulation, warranting further functional validation.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
Subject
/ 631/154
/ 631/378
/ Animals
/ Berberine Alkaloids - chemistry
/ Berberine Alkaloids - pharmacokinetics
/ Berberine Alkaloids - pharmacology
/ Chickens
/ Chloride
/ Diazepam
/ Humanities and Social Sciences
/ Hypnotics and Sedatives - pharmacokinetics
/ Hypnotics and Sedatives - pharmacology
/ Insomnia
/ Latency
/ Male
/ Molecular Docking Simulation
/ Receptors, GABA-A - chemistry
/ Receptors, GABA-A - metabolism
/ Science
/ Sleep
/ Sodium
/ Toxicity
